Skip to main content
Signal8

PROCYON CORP (PCYN)

Procyon Corporation, along with its affiliated entities, specializes in the development and distribution of proprietary medical solutions. Their primary focus is on addressing various skin conditions, including pressure and stasis ulcers, general wounds, dermatitis, inflammation, and other dermatological issues, predominantly within the United States. The company offers a diverse array of products. Under the AMERIGEL brand, they provide sophisticated skin and wound healing items such as hydrogel dressings, post-operative surgical kits, saline wound rinses, and protective lotions, in addition to hand sanitizer. Their HELIX3 line features Bioactive Collagen products, available in both powder and matrix forms. For comprehensive wound management, the AMERX brand includes various dressing types like calcium alginate, foam, gauze, and hydrocolloid, as well as complete wound care kits containing components like collagen matrix, collagen powder, foam, and hydrogel. Furthermore, Procyon markets compression garments under the EXTREMIT-EASE name. These offerings are distributed through multiple channels: to institutional clients such as hospitals, wound care clinics, nursing homes, home health agencies, and medical practitioners via distributors, and directly to individual consumers through online sales, direct purchases, and independent or chain pharmacies. Founded in 1987, the company's operations are headquartered in Clearwater, Florida.

Sector: Pharmaceutical Preparations

Industry: Drug Manufacturers - Specialty & Generic

Procyon Corporation logo

Procyon Corporation

OTC:PCYNHealthcare
Mkt Cap$1.5M
Float2.94M
O/S8.12M
Inst Own-
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$1.50M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership0.00%

based on 8.12M shares outstanding

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeOTC
CountryUSUS
IPO DateDec 11, 1996
Shares Outstanding8.12M
Float2.94M
Company Overview

Procyon Corporation, along with its affiliated entities, specializes in the development and distribution of proprietary medical solutions. Their primary focus is on addressing various skin conditions, including pressure and stasis ulcers, general wounds, dermatitis, inflammation, and other dermatological issues, predominantly within the United States.

The company offers a diverse array of products. Under the AMERIGEL brand, they provide sophisticated skin and wound healing items such as hydrogel dressings, post-operative surgical kits, saline wound rinses, and protective lotions, in addition to hand sanitizer. Their HELIX3 line features Bioactive Collagen products, available in both powder and matrix forms. For comprehensive wound management, the AMERX brand includes various dressing types like calcium alginate, foam, gauze, and hydrocolloid, as well as complete wound care kits containing components like collagen matrix, collagen powder, foam, and hydrogel. Furthermore, Procyon markets compression garments under the EXTREMIT-EASE name. These offerings are distributed through multiple channels: to institutional clients such as hospitals, wound care clinics, nursing homes, home health agencies, and medical practitioners via distributors, and directly to individual consumers through online sales, direct purchases, and independent or chain pharmacies. Founded in 1987, the company's operations are headquartered in Clearwater, Florida.

Leadership

Fred W. Suggs, Jr.

Director

James B. Anderson

Chief Financial Officer & Director

Joseph R. Treshler

Director

Justice W. Anderson

Chief Executive Officer, President & Director

Employees

19

Country

US

Sector

Healthcare

Website

procyoncorp.com

Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
InsiderTypeShares
McComas Steven profile photoMcComas StevenGrant/Award5.6K
McCullough Monica profile photoMcCullough MonicaGrant/Award7.2K
Treshler Joseph Raymond profile photoTreshler Joseph RaymondGrant/Award7.4K
SUGGS FRED WILSON JR profile photoSUGGS FRED WILSON JRGrant/Award12.8K
Shareholders
0.0%
Institutional
(0)
0.2%
Insiderⓘ
(3)
0.0%
5%+ Owners
(0)
99.8%
Unattributed (incl. retail)ⓘ
Insider0.2%
Unattributed (incl. retail)99.8%
Top Shareholders
NameShares%
Treshler Joseph Raymond profile photo
Treshler Joseph Raymond
Director
7.4K0.1%
McCullough Monica profile photo
McCullough Monica
Director
7.2K0.1%
McComas Steven profile photo
McComas Steven
Director
5.6K0.1%
Sources: Form 4O/S: 8.1M · as of 28 Sep 2024 · SEC cover page
Insiders & Institutional Holders
52-Week Range
Volume
Average Daily Volume2.80K

30d Avg

2.80K

60d Avg

1.68K

90d Avg

4.43K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...